The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing
Primary Purpose
Missing Tooth
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Platform-matched dental implant
Platform-switched dental implant
Sponsored by
About this trial
This is an interventional treatment trial for Missing Tooth focused on measuring Dental Implant
Eligibility Criteria
Inclusion Criteria:
- 1. Have one edentulous site bordered by 2 teeth.
- 2. Healthy persons at least 18 years old.
- 3. Understands and has signed the informed consent.
Exclusion Criteria:
- 1. Patients with uncontrolled diabetes, immune disease, or systemic disease that significantly affects the periodontium.
- 2. Previous head and neck radiation.
- 3. Patients who have been on IV bisphosphonates or oral bisphosphonates for > 3 years.
- 4. Smokers.
- 5. Patients who need prophylactic antibiotics prior to dental procedures.
- 6. Patients with allergy to any medication or material used in the study.
- 7. Chemotherapy in the previous 12 months.
- 8. Severe psychological problems.
- 9. Patients unable to sign the informed consent.
- 10. Pregnant patients.
- 11. History of allergy to common dentifrice ingredients.
Sites / Locations
- University of Louisville
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Platform-matched dental implant
Platform-switched dental implant
Arm Description
Platform-matched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Platform-switched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Outcomes
Primary Outcome Measures
Marginal alveolar bone loss
Bone loss will be measured radiographically using a stent
Secondary Outcome Measures
Buccal implant recession
Buccal implant recession will be measured using a North Carolina probe using the adjacent teeth and incisal edge of the crown
Papilla fill
Presence or absence of black triangle apical to the contact point
Buccal soft tissue thickness around implant
Thickness will be measured with an endodontic file using a rubber stopper (objective measure of tissue thickness by penetrating tissue and measuring the thickness in mm).
Full Information
NCT ID
NCT02536716
First Posted
August 28, 2015
Last Updated
September 8, 2020
Sponsor
University of Louisville
1. Study Identification
Unique Protocol Identification Number
NCT02536716
Brief Title
The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing
Official Title
The Effect of Platform-Matching Versus Platform-Switching Using Standard Internal Versus Tapered Internal Plus Dental Implants on Peri-implant Hard and Soft Tissue Healing
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
January 12, 2016 (Actual)
Primary Completion Date
July 21, 2017 (Actual)
Study Completion Date
July 21, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Louisville
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To compare platform-switched implants to platform-matched implants for replacement of a single missing tooth and their effect on: 1) Interproximal alveolar crest level in relation to implant platform. 2) Buccal implant recession. 3) Presence or absence of black triangle apical to the contact point. 4) Implant Success. 5) Adequate buccal tissue thickness.
Detailed Description
Thirty patients will have a dental implant placed. Fifteen patients will be randomly selected by a coin toss to receive a platform-switched implant while the other fifteen will receive platform-matched implant. Each patient will receive a diagnostic work-up including standardized radiographs (periapicals), study casts, clinical photographs, and a clinical examination of teeth adjacent to the edentulous sites. Pre-surgical preparation will include detailed oral hygiene instructions. Baseline data will be collected at initial exam, and at 2, 4, 6, and 12 months. Parameters measured will include: plaque index, gingival index, probing depth, keratinized tissue, bleeding on probing, and digital radiographic examination. Pre-surgical measurements will include: cemento-enamel junction to osseous crest on adjacent teeth by direct measurement at surgery, and by radiograph at baseline, 2, 4, 6, and 12 months, periodontal form, periodontal biotype, tooth shape, and papilla harmony. Patients will be randomly selected for treatment group assignment using a coin toss before surgery by the mentor. One investigator who is unaware of group assignment will perform all baseline examinations and all follow-up examinations. Means and standard deviations will be calculated for all parameters. A paired t-test will be used to evaluate the statistical significance of the differences between initial and final data. An unpaired t-test will be used to evaluate statistical differences between the test and control groups. A sample size of 15 gives 80% statistical power to detect a difference of 0.5 mm of implant bone loss between groups. All surgical procedures will be completed by one operator under the direction of one mentor. Pre-surgical measurements will be taken first. Local anesthesia will be administered. The surgical procedure will consist of the reflection of full thickness flaps to expose the alveolar crest. The implant platform will be placed 3 to 4 mm apical to the mid-facial gingival margin using dental implant osteotomy drills for preparation of the site. The surgical procedures will be documented with clinical photographs. Sutures will be used to close the flap and bury the implant under the tissue. Records will be kept of healing periodically for the first 8 weeks, then at 4, 6 and 12 months. The test group will use a BioHorizons Tapered Internal Plus "platform-switched" implant. The control group will be BioHorizons standard Internal "platform-matched" implant. All patients will be seen at 1-2, 4, 6 and 8 weeks to monitor healing. At week 8 the implant will be uncovered surgically and provisionalized, and at the 4 month visit the final crown will be placed. Subsequent examinations will take place at 6 and 12 months. Post-surgically, patients will take an antibiotic (doxycycline hyclate 100 mg once a day for two weeks), an analgesic (Vicodin ES every 4-6 hours as needed for pain), and an anti-inflammatory agent (Naproxen 375mg every 12 hours for one week). At post-operative visits plaque removal, and oral hygiene instruction, as needed, will be performed along with clinical photographs and standardized radiographs as scheduled. The results of this study will allow comparison of peri-implant soft and hard tissue healing following placement of a BioHorizons "platform-switched" Tapered Internal Plus implant versus a standard Internal "platform-matched" implant in terms of the effect on marginal bone loss, buccal recession, and papilla fill.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Missing Tooth
Keywords
Dental Implant
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Platform-matched dental implant
Arm Type
Active Comparator
Arm Description
Platform-matched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Arm Title
Platform-switched dental implant
Arm Type
Experimental
Arm Description
Platform-switched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Intervention Type
Procedure
Intervention Name(s)
Platform-matched dental implant
Intervention Description
A platform-matched dental implant will be placed surgically, restored with a crown and evaluated for up to 12 months.
Intervention Type
Procedure
Intervention Name(s)
Platform-switched dental implant
Intervention Description
A platform-switched dental implant will be placed surgically, restored with a crown and evaluated for up to 12 months.
Primary Outcome Measure Information:
Title
Marginal alveolar bone loss
Description
Bone loss will be measured radiographically using a stent
Time Frame
12-months post dental implant placement
Secondary Outcome Measure Information:
Title
Buccal implant recession
Description
Buccal implant recession will be measured using a North Carolina probe using the adjacent teeth and incisal edge of the crown
Time Frame
12-months post dental implant placement
Title
Papilla fill
Description
Presence or absence of black triangle apical to the contact point
Time Frame
12-months post dental implant placement
Title
Buccal soft tissue thickness around implant
Description
Thickness will be measured with an endodontic file using a rubber stopper (objective measure of tissue thickness by penetrating tissue and measuring the thickness in mm).
Time Frame
12-months post dental implant placement
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
1. Have one edentulous site bordered by 2 teeth.
2. Healthy persons at least 18 years old.
3. Understands and has signed the informed consent.
Exclusion Criteria:
1. Patients with uncontrolled diabetes, immune disease, or systemic disease that significantly affects the periodontium.
2. Previous head and neck radiation.
3. Patients who have been on IV bisphosphonates or oral bisphosphonates for > 3 years.
4. Smokers.
5. Patients who need prophylactic antibiotics prior to dental procedures.
6. Patients with allergy to any medication or material used in the study.
7. Chemotherapy in the previous 12 months.
8. Severe psychological problems.
9. Patients unable to sign the informed consent.
10. Pregnant patients.
11. History of allergy to common dentifrice ingredients.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Henry Greenwell, DMD
Organizational Affiliation
University of Louisville
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Louisville
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing
We'll reach out to this number within 24 hrs